索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]倪钧.氧化应激相关酶介导心血管疾病中血管内膜增生的机制[J].国际心血管病杂志,2016,06:362-364.
点击复制

氧化应激相关酶介导心血管疾病中血管内膜增生的机制(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2016年06期
页码:
362-364
栏目:
综述
出版日期:
2016-11-20

文章信息/Info

Title:
-
作者:
倪钧
200025 上海交通大学医学院附属瑞金医院心内科
Author(s):
-
关键词:
氧化应激; 氧化还原酶; 血管内膜增生; 心血管疾病
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2016.06.012
文献标识码:
-
摘要:
体内多种氧化应激相关酶,如血红素氧合酶-1、髓过氧化物酶以及还原型烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶,均与血管内膜增生过程相关。深入研究体内氧化还原酶及其介导的氧化应激过程,有利于了解心血管疾病中血管内膜增生的机制,寻求合适的治疗靶点。
Abstract:
-

参考文献/References

[1] Hansson GK. Inflammation, atherosclerosis and coronary artery disease[J]. N Engl J Med, 2005, 352(16): 1685-1695.
[2] Park SJ, Kim YH. Current status of percutaneous coronary intervention with drug-eluting stents in Asia[J]. Circulation, 2008, 118(25): 2730-2737.
[3] Windecker S, Meier B. Late coronary stent thrombosis[J]. Circulation, 2007, 116(17): 1952-1965.
[4] Schearts RS, Henry TD. Pathophysiology of coronary artery stenosis[J]. Rev Cardiovasc Med, 2002, 3(S5): S4-9.
[5] Muto A, Fitzgerald TN, Pimiento JM, et al. Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons[J]. J Vasc Surg, 2007, 45(Suppl A): A15-24.
[6] Souza HP, Souza LC, Anastacio VM, et al. Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity[J]. Free Radic Biol Med, 2000, 28(8):1232-1242.
[7] Pollman MJ, Hall JL, Gibbons GH. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury: influence of redox state and cell phenotype[J]. Circ Res, 1999,84(1):113-121.
[8] Nunes GL, Robinson K, Kalynych A, et al. Vitamins C and E inhibit O2 production in the pig coronary artery[J]. Circulation, 1997, 96(10):3593-3601.
[9] Freyschuss A, Stiko-Rahm A, Swedenborg J, et al. Antioxidant treatment inhibits the development of intimal thickening after ballooninjury of the aorta in hypercholesterolemic rabbits[J]. J Clin Invest, 1993, 91(4):1282-1288.
[10] Cheng C, Noorderloos M, van Deel ED, et al. Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque[J]. Circulation, 2009, 119(23): 3017-3027.
[11] Li M, Peterson S, Husney D, et al. Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice[J]. Cell Cycle, 2007, 6(5): 567-571.
[12] Deng Y, Wu B, Witting P, et al. Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1[J]. Circulation, 2004, 110(13): 1855-1860.
[13] Beck K, Wu BJ, Ni J, et al. Interplay between heme oxygenase-1 and the multifunctional transcription factor yin yang 1 in the inhibition of intimal hyperplasia[J]. Circ Res, 2010, 107(12): 1490-1497.
[14] Kasai T, Miyauchi K, Kubota N, et al. Probucol therapy improves long-term(>10-year)survival after complete revascularization: A propensity analysis[J]. Atherosclerosis, 2012, 220(2): 463-469.
[15] Park KM, Kim CH, Lee HY, et al. Does “Late catch-up” exist in drug-eluting stents: insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel stent? [J]. Am Heart J, 2010, 159(3): 446-453.
[16] Levonen AL, Inkala M, Heikura T, et al. Nrf2 gene transfer induces antioxidant enzymes and suppresses smooth muscle cell growth in vitro and reduces oxidative stress in rabbit aorta in vivo[J].Arterioscler Thromb Vasc Biol, 2007, 27(4):741-747.
[17] Loscalzo J. Oxidative stress: a key determinant of atherothrombosis[J]. Biochem Soc Trans, 2003, 31(Pt 5): 1059-1061.
[18] Yang J, Cheng Y, Ji R, et al. Novel model of inflammatory neointima formation reveals a potential role of myeloperoxidase in neointimal hyperplasia[J]. Am J Physiol Heart Circ Physio, 2006, 291(6):H3087-3093.
[19] Tiyerili V, Camara B, Becher MU, et al. Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in mice[J]. Int J Cardiol, 2015, 204(2):29-36.
[20] Violi F, Basili S, Nigro C, et al. Role of NADPH oxidase in atherosclerosis[J]. Future Cardiol, 2009, 5(1): 83-92.
[21] Di Marco E, Gray SP, Chew P, et al. Pharmacological inhibition of NOX reduces atherosclerostic lesions, vascular ROS and immune-inflammatory response in diabetic Apoe(-/-)mice[J]. Diabetologia, 2014, 57(3): 633-642.
[22] Jing YJ, Ni JW, Ding FH, et al. p-Cresyl sulfate is associated with carotid arteriosclerosis in hemodialysis patients and promotes atherogenesis in apoE-/- mice [J]. Kidney Int, 2016, 89(2):439-449.
[23] Victor VM, Apostolova N, Herance R, et al. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy[J]. Curr Med Chem, 2009, 16(35): 4654-4667.

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2016-11-20